UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

Summary

This study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies. The treatment is given by injection and is designed to train the immune system to tolerate peanut exposure over time.

Timeline

Start

2026-02-18

Primary completion

2027-03-01

Completion

2027-11-01

Drugs

Indications